CI

Cigna GroupNYSE CI Stock Report

Last reporting period 30 Jun, 2024

Updated 16 Sep, 2024

Last price

Market cap $B

101.24

Mega

Exchange

XNYS - New York Stock Exchange, Inc

CI Stock Analysis

CI

Avoid

Based on Eyestock quantitative analysis, CI`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

32/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-52.0 %

Greatly overvalued

Market cap $B

101.24

Dividend yield

1.82 %

Shares outstanding

297.06 B

The Cigna Group is engaged in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 71,300 full-time employees. The firm includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. Cigna Healthcare is the health benefits provider that advocates for better health through every stage of life. Cigna Healthcare offers a range of insurance plans and products that focus on all aspects of well-being-physical and emotional. Cigna Healthcare consists of its U.S. Commercial, U.S. Government and International Health. U.S. Commercial includes employer-sponsored health plans and solutions. U.S. Government includes Medicare and individual and family health plans and solutions. International Health includes individual and employer-sponsored health plans and solutions. Evernorth Health Services creates pharmacy, care, and benefits solutions that improve health and increase vitality. Evernorth Health Services solutions include Evernorth Home-Based Care, Health Connect 360 and others.

View Section: Eyestock Rating